researcher comment: os boost with enzalutamide in metastatic cspc setting | christopher sweeney
Published 5 years ago • 97 plays • Length 3:11Download video MP4
Download video MP3
Similar videos
-
2:46
dr. sweeney on the phase iii enzamet trial in metastatic hormone-sensitive prostate cancer
-
1:21
prostate cancer research at esmo 2020: christopher sweeney, mbbs
-
2:58
expert comment: enzamet and titan trials | earle burgess
-
1:10
preside: investigating continued treatment with enzalutamide in pc following disease progression
-
5:29
key considerations for the vision trial of lupsma in mcrpc | mary-ellen taplin
-
1:07
dr. penson on treatment selection in metastatic hormone-sensitive prostate cancer
-
1:09
dr. sweeney on chemotherapy in prostate cancer
-
0:44
prostate cancer metastasize and spine compression - bone health and cancer #shorts
-
0:22
bernie's psa levels - gatewayc metastatic prostate cancer course
-
8:44
finding an oncologist for advanced disease | scanning for metastases early | mark scholz, md | pcri
-
1:00
"bob's story" - focal hifu at maimonides prostate center
-
1:07
mayo clinic researchers discover gene biomarkers for prostate cancer detection
-
2:01
prostate cancer and benign hyperplasia: evaluation | protocol preview
-
1:59
latest genomic insights for prostate cancer treatment
-
4:05
presto study
-
3:13
metastatic prostate cancer treatment sequencing: emerging research
-
55:35
is there still a role for docetaxel in mhspc?
-
3:50
detection and risk stratification of localized prostate cancer